-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

The Role of Maintenance Therapy for Multiple Myeloma in the Era of Novel Agents

Program: Education Program
Session: Multiple Advances in Myeloma
Saturday, December 5, 2015, 4:00 PM-5:30 PM
Hall D, Level 2 (Orange County Convention Center)
Sunday, December 6, 2015, 7:30 AM-9:00 AM
Chapin Theater (W320), Level 3 (Orange County Convention Center)

Thierry Facon, MD

Maladies du Sang, Lille University Hospital, Lille, France

Disclosures: Facon: Celgene Corporation: Consultancy , Membership on an entity’s Board of Directors or advisory committees . Off Label Use: Lenalidomide.

See more of: Multiple Advances in Myeloma
See more of: Education Program
<< Previous Presentation | Next Presentation >>